Will the recently reinstated clsi 2020 breakpoints of norfloxacin for urinary isolates work for India? - Tertiary care experience and evidence

Indian J Med Microbiol. 2019 Oct-Dec;37(4):600-601. doi: 10.4103/ijmm.IJMM_20_142.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacteria / drug effects*
  • Drug Resistance, Bacterial / drug effects
  • Humans
  • India
  • Microbial Sensitivity Tests / methods
  • Norfloxacin / therapeutic use*
  • Tertiary Healthcare / methods
  • Urinary Tract Infections / drug therapy*
  • Urinary Tract Infections / microbiology

Substances

  • Anti-Bacterial Agents
  • Norfloxacin